{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:28:10Z","timestamp":1792020490709,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foundation of Zhejiang Provincial Education Department","award":["Y202146832"],"award-info":[{"award-number":["Y202146832"]}]},{"name":"Foundation of Zhejiang Provincial Education Department","award":["Y202249328"],"award-info":[{"award-number":["Y202249328"]}]},{"name":"Science and Technology program of Jinhua Science and Technology Bureau","award":["2020-4-104"],"award-info":[{"award-number":["2020-4-104"]}]},{"name":"Science and Technology program of Yiwu Science and Technology Bureau","award":["2020-3-059"],"award-info":[{"award-number":["2020-3-059"]}]},{"name":"Foundation of The fourth Affiliated Hospital Zhejiang University School of Medicine","award":["JG20230203"],"award-info":[{"award-number":["JG20230203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Zolpidem is a non-benzodiazepine hypnotic widely used to manage insomnia. Zolpidem-triggered atrial fibrillation (AF) in patients with cardiomyopathy has never been reported before.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 40-year-old man with Duchenne muscular dystrophy-related cardiomyopathy attempted suicide and developed new-onset AF after zolpidem overdose. One year before admission, the patient visited our clinic due to chest discomfort and fatigue after daily walks for 1 month; both electrocardiography (ECG) and 24-hour Holter ECG results did not detect AF. After administration of cardiac medication (digoxin 0.125\u00a0mg\/day, spironolactone 40\u00a0mg\/day, furosemide 20\u00a0mg\/day, bisoprolol 5\u00a0mg\/day, sacubitril\/valsartan 12\/13\u00a0mg\/day), he felt better. AF had never been observed before this admission via continuous monitoring during follow-up. Sixteen days before admission, the patient saw a sleep specialist and started zolpidem tartrate tablets (10\u00a0mg\/day) due to insomnia for 6 months; ECG results revealed no significant change. The night before admission, the patient attempted suicide by overdosing on 40\u00a0mg of zolpidem after an argument, which resulted in severe lethargy. Upon admission, his ECG revealed new-onset AF, necessitating immediate cessation of zolpidem. Nine hours into admission, AF spontaneously terminated into normal sinus rhythm. Results from the ECG on the following days and the 24-hour Holter ECG at 1-month follow-up showed that AF was not detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides valuable clinical evidence indicating that zolpidem overdose may induce AF in patients with cardiomyopathy. It serves as a critical warning for clinicians when prescribing zolpidem, particularly for patients with existing heart conditions. Further large-scale studies are needed to validate this finding and to explore the mechanisms between zolpidem and AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-024-04016-5","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:02:17Z","timestamp":1720083737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaolin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"issue":"1","key":"4016_CR1","doi-asserted-by":"publisher","first-page":"24927","DOI":"10.52965\/001c.24927","volume":"9","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Wu N, Ghaffar YT, Prejean R, et al. Zolpidem: Efficacy and Side effects for Insomnia. Health Psychol Res. 2021;9(1):24927. https:\/\/doi.org\/10.52965\/001c.24927.","journal-title":"Health Psychol Res"},{"issue":"2","key":"4016_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afx167","volume":"47","author":"N Treves","year":"2018","unstructured":"Treves N, Perlman A, Kolenberg Geron L, Asaly A, et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018;47(2):201\u20138. https:\/\/doi.org\/10.1093\/ageing\/afx167.","journal-title":"Age Ageing"},{"issue":"1","key":"4016_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/NMD.0000000000001074","volume":"208","author":"J Westermeyer","year":"2020","unstructured":"Westermeyer J, Carr TM. Zolpidem-Associated consequences: an updated literature review with Case Reports. J Nerv Ment Dis. 2020;208(1):28\u201332. https:\/\/doi.org\/10.1097\/NMD.0000000000001074.","journal-title":"J Nerv Ment Dis"},{"key":"4016_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.smrv.2017.01.005","volume":"37","author":"HM Stallman","year":"2018","unstructured":"Stallman HM, Kohler M, White J. Medication induced sleepwalking: a systematic review. Sleep Med Rev. 2018;37:105\u201313. https:\/\/doi.org\/10.1016\/j.smrv.2017.01.005.","journal-title":"Sleep Med Rev"},{"issue":"4","key":"4016_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","volume":"22","author":"F Schifano","year":"2019","unstructured":"Schifano F, Chiappini S, Corkery JM, Guirguis A. An insight into Z-Drug abuse and dependence: an examination of reports to the European Medicines Agency Database of suspected adverse drug reactions. Int J Neuropsychopharmacol. 2019;22(4):270\u20137. https:\/\/doi.org\/10.1093\/ijnp\/pyz007.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"4016_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.5664\/jcsm.7240","volume":"14","author":"G Chiaro","year":"2018","unstructured":"Chiaro G, Castelnovo A, Bianco G, Maffei P, et al. Severe chronic abuse of Zolpidem in Refractory Insomnia. J Clin Sleep Med. 2018;14(7):1257\u20139. https:\/\/doi.org\/10.5664\/jcsm.7240.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"4016_CR7","doi-asserted-by":"publisher","first-page":"19l02506","DOI":"10.4088\/PCC.19l02506","volume":"22","author":"L Suarez","year":"2020","unstructured":"Suarez L, Kolla BP, Hall-Flavin D, Mansukhani MP. QTc prolongation secondary to Zolpidem Use. Prim Care Companion CNS Disord. 2020;22(2):19l02506. https:\/\/doi.org\/10.4088\/PCC.19l02506.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"6","key":"4016_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/15563650.2019.1663206","volume":"58","author":"HJ Ahn","year":"2020","unstructured":"Ahn HJ, Jeong WJ, Kim KJ, Kim SC, et al. Serial plasma and urine measurements of a patient with acute intoxication of zolpidem and flunitrazepam resulting in QT prolongation and ventricular tachycardia. Clin Toxicol (Phila). 2020;58(6):501\u20133. https:\/\/doi.org\/10.1080\/15563650.2019.1663206.","journal-title":"Clin Toxicol (Phila)"},{"key":"4016_CR9","doi-asserted-by":"publisher","first-page":"923939","DOI":"10.3389\/fphar.2022.923939","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Lin Y, Ren W, Fang Z, et al. Adverse drug reactions and correlations with drug-drug interactions: a retrospective study of reports from 2011 to 2020. Front Pharmacol. 2022;13:923939. https:\/\/doi.org\/10.3389\/fphar.2022.923939.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4016_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jsmc.2020.08.011","volume":"15","author":"EW MacKintosh","year":"2020","unstructured":"MacKintosh EW, Chen ML, Benditt JO. Lifetime care of Duchenne muscular dystrophy. Sleep Med Clin. 2020;15(4):485\u201395. https:\/\/doi.org\/10.1016\/j.jsmc.2020.08.011.","journal-title":"Sleep Med Clin"},{"issue":"1","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, et al. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"4016_CR12","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/jpm12101645","volume":"12","author":"X Hu","year":"2022","unstructured":"Hu X, Jong GP, Wang L, Lin MC, et al. Hypnotics Use is Associated with elevated Incident Atrial Fibrillation: a propensity-score matched analysis of Cohort Study. J Pers Med. 2022;12(10):1645. https:\/\/doi.org\/10.3390\/jpm12101645.","journal-title":"J Pers Med"},{"issue":"4","key":"4016_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccep.2019.08.007","volume":"11","author":"DH Lau","year":"2019","unstructured":"Lau DH, Linz D, Sanders P. New findings in Atrial Fibrillation mechanisms. Card Electrophysiol Clin. 2019;11(4):563\u201371. https:\/\/doi.org\/10.1016\/j.ccep.2019.08.007.","journal-title":"Card Electrophysiol Clin"},{"issue":"1","key":"4016_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms23010006","volume":"23","author":"M Sagris","year":"2021","unstructured":"Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, et al. Atrial fibrillation: Pathogenesis, predisposing factors, and Genetics. Int J Mol Sci. 2021;23(1):6. https:\/\/doi.org\/10.3390\/ijms23010006.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"e19615","DOI":"10.1097\/MD.0000000000019615","volume":"99","author":"Y Fu","year":"2020","unstructured":"Fu Y, He W, Ma J, Wei B. Relationship between psychological factors and atrial fibrillation: a meta-analysis and systematic review. Med (Baltim). 2020;99(16):e19615. https:\/\/doi.org\/10.1097\/MD.0000000000019615.","journal-title":"Med (Baltim)"},{"key":"4016_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijcard.2022.05.048","volume":"362","author":"H Wu","year":"2022","unstructured":"Wu H, Li C, Li B, Zheng T, et al. Psychological factors and risk of atrial fibrillation: a meta-analysis and systematic review. Int J Cardiol. 2022;362:85\u201392. https:\/\/doi.org\/10.1016\/j.ijcard.2022.05.048.","journal-title":"Int J Cardiol"},{"issue":"5","key":"4016_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"issue":"6","key":"4016_CR18","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of Heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u201361. https:\/\/doi.org\/10.1161\/CIR.0000000000000509.","journal-title":"Circulation"},{"issue":"5","key":"4016_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1755-5949.2010.00158.x","volume":"17","author":"A Dang","year":"2011","unstructured":"Dang A, Garg A, Rataboli PV. Role of zolpidem in the management of insomnia. CNS Neurosci Ther. 2011;17(5):387\u201397. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00158.x.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"4016_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2165\/00003088-199529030-00002","volume":"29","author":"P Salv\u00e0","year":"1995","unstructured":"Salv\u00e0 P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet. 1995;29(3):142\u201353. https:\/\/doi.org\/10.2165\/00003088-199529030-00002.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"4016_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jsmc.2013.04.004","volume":"8","author":"JC Ong","year":"2013","unstructured":"Ong JC, Crawford MR. Insomnia and obstructive sleep apnea. Sleep Med Clin. 2013;8(3):389\u201398. https:\/\/doi.org\/10.1016\/j.jsmc.2013.04.004.","journal-title":"Sleep Med Clin"},{"issue":"5","key":"4016_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11910-017-0750-1","volume":"17","author":"A LoMauro","year":"2017","unstructured":"LoMauro A, D\u2019Angelo MG, Aliverti A. Sleep disordered breathing in Duchenne muscular dystrophy. Curr Neurol Neurosci Rep. 2017;17(5):44. https:\/\/doi.org\/10.1007\/s11910-017-0750-1.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"4016_CR23","doi-asserted-by":"publisher","first-page":"1701344","DOI":"10.1183\/13993003.01344-2017","volume":"50","author":"JC Carberry","year":"2017","unstructured":"Carberry JC, Fisher LP, Grunstein RR, Gandevia SC, et al. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem. Eur Respir J. 2017;50(6):1701344. https:\/\/doi.org\/10.1183\/13993003.01344-2017.","journal-title":"Eur Respir J"},{"issue":"6","key":"4016_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/jamacardio.2018.0095","volume":"3","author":"D Linz","year":"2018","unstructured":"Linz D, McEvoy RD, Cowie MR, Somers VK, et al. Associations of Obstructive Sleep Apnea with Atrial Fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3(6):532\u201340. https:\/\/doi.org\/10.1001\/jamacardio.2018.0095.","journal-title":"JAMA Cardiol"},{"issue":"6","key":"4016_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.rmed.2007.12.026","volume":"102","author":"G Stege","year":"2008","unstructured":"Stege G, Vos PJ, van den Elshout FJ, Richard Dekhuijzen PN, et al. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008;102(6):801\u201314. https:\/\/doi.org\/10.1016\/j.rmed.2007.12.026.","journal-title":"Respir Med"},{"issue":"9","key":"4016_CR26","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.hrthm.2010.03.020","volume":"7","author":"IH Stevenson","year":"2010","unstructured":"Stevenson IH, Roberts-Thomson KC, Kistler PM, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7(9):1263\u201370. https:\/\/doi.org\/10.1016\/j.hrthm.2010.03.020.","journal-title":"Heart Rhythm"},{"issue":"4","key":"4016_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3904\/kjim.2016.282","volume":"33","author":"YH Kim","year":"2018","unstructured":"Kim YH, Kim HB, Kim DH, Kim JY, et al. Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies. Korean J Intern Med. 2018;33(4):727\u201336. https:\/\/doi.org\/10.3904\/kjim.2016.282.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"4016_CR28","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00228-018-2515-4","volume":"74","author":"S Mesrine","year":"2018","unstructured":"Mesrine S, Gusto G, Clavel-Chapelon F, Boutron-Ruault MC, et al. Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years. Eur J Clin Pharmacol. 2018;74(11):1475\u201384. https:\/\/doi.org\/10.1007\/s00228-018-2515-4.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"4016_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/FBP.0b013e328343d78a","volume":"22","author":"SC Licata","year":"2011","unstructured":"Licata SC, Mashhoon Y, Maclean RR, Lukas SE. Modest abuse-related subjective effects of zolpidem in drug-naive volunteers. Behav Pharmacol. 2011;22(2):160\u20136. https:\/\/doi.org\/10.1097\/FBP.0b013e328343d78a.","journal-title":"Behav Pharmacol"},{"issue":"2","key":"4016_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2165\/00003495-199040020-00008","volume":"40","author":"HD Langtry","year":"1990","unstructured":"Langtry HD, Benfield P, Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs. 1990;40(2):291\u2013313. https:\/\/doi.org\/10.2165\/00003495-199040020-00008.","journal-title":"Drugs"},{"issue":"3","key":"4016_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/js970316d","volume":"87","author":"Y Horikiri","year":"1998","unstructured":"Horikiri Y, Suzuki T, Mizobe M. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans. J Pharm Sci. 1998;87(3):289\u201394. https:\/\/doi.org\/10.1021\/js970316d.","journal-title":"J Pharm Sci"},{"issue":"2","key":"4016_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/004982599238722","volume":"29","author":"L Salphati","year":"1999","unstructured":"Salphati L, Benet LZ. Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A. Xenobiotica. 1999;29(2):171\u201385. https:\/\/doi.org\/10.1080\/004982599238722.","journal-title":"Xenobiotica"},{"issue":"1","key":"4016_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13063-021-05236-2","volume":"22","author":"PJ Garcia","year":"2021","unstructured":"Garcia PJ, Mundaca H, Ugarte-Gil C, Leon P, et al. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Trials. 2021;22(1):262. https:\/\/doi.org\/10.1186\/s13063-021-05236-2.","journal-title":"Trials"},{"issue":"1","key":"4016_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1211\/jpp\/61.01.0007","volume":"61","author":"KH Yang","year":"2009","unstructured":"Yang KH, Choi YH, Lee U, Lee JH, et al. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. J Pharm Pharmacol. 2009;61(1):47\u201354. https:\/\/doi.org\/10.1211\/jpp\/61.01.0007.","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"4016_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s002130100769","volume":"156","author":"F Mailliet","year":"2001","unstructured":"Mailliet F, Galloux P, Poisson D. Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats. Psychopharmacology. 2001;156(4):417\u201326. https:\/\/doi.org\/10.1007\/s002130100769.","journal-title":"Psychopharmacology"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04016-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:04:50Z","timestamp":1720083890000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04016-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04016-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the publication of this study was obtained from the Ethics Committee of The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Informed consent was obtained from the patient included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}